The interaction test demonstrated that the effects of SGLT2 inhibitors on superficial keratopathy development were similar in all subgroups despite the factors of stratification (all P > 0.05), and same results were observed regarding the relationship between SGLT2 inhibitors usage and infectious keratitis development (all P > 0.05) (Table 5). This evidence concerns the gene SLC5A2 and keratitis.